Development and Application of Anticancer Nanomedicine

Abstract

This chapter describes the state-of-the-art advances in the field of cancer nanotechnology that bring the science closer to clinical realization of nanomedicine-mediated cancer therapy and targeting. The development of various types of nanomedicines and their current status of clinical translation is reviewed, followed by the discussion of studies for improving the biodistribution, tumor penetration, and cellular uptake of nanomedicines. Recent development of nanomedicine-controlled formulation and conjugation techniques, as well as the potential and the challenge of nanomedicine-mediated cancer targeting, is also discussed.